110 related articles for article (PubMed ID: 18202755)
21. EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women.
El Hamdani W; Amrani M; Attaleb M; Laantri N; Ennaji MM; Khyatti M; El Mzibri M
Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1373-84. PubMed ID: 20937225
[TBL] [Abstract][Full Text] [Related]
22. Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV.
Vázquez-Vega S; Sánchez-Suárez LP; Contreras-Paredes A; Castellanos-Juárez E; Peñarroja-Flores R; Lizano-Soberón M; Andrade-Cruz R; García-Carrancá A; Benítez-Bribiesca L
Cancer Biomark; 2010-2011; 8(6):341-50. PubMed ID: 22072122
[TBL] [Abstract][Full Text] [Related]
23. Correlation of p16 and pRb expression with HPV detection in Bowen's disease.
Willman JH; Heinz D; Golitz LE; Shroyer KR
J Cutan Pathol; 2006 Sep; 33(9):629-33. PubMed ID: 16965338
[TBL] [Abstract][Full Text] [Related]
24. P16 as a molecular biomarker of cervical adenocarcinoma.
Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
[TBL] [Abstract][Full Text] [Related]
25. P16INK4A--A possible marker in HPV persistence screening.
Bleotu C; Botezatu A; Goia CD; Socolov D; Corniţescu F; Teleman S; Huică I; Iancu I; Anton G
Roum Arch Microbiol Immunol; 2009; 68(3):183-9. PubMed ID: 20361540
[TBL] [Abstract][Full Text] [Related]
26. Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis.
Sobti RC; Singh N; Hussain S; Suri V; Bharadwaj M; Das BC
J Recept Signal Transduct Res; 2010 Jun; 30(3):178-88. PubMed ID: 20415542
[TBL] [Abstract][Full Text] [Related]
27. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16/18 expression of endocervical glandular lesions: relationship with p53 and MIB-1 Expressions.
Yoon HK; Kim YJ; Kang MS
J Korean Med Sci; 2001 Apr; 16(2):169-74. PubMed ID: 11306742
[TBL] [Abstract][Full Text] [Related]
29. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions.
Laco J; Slaninka I; Jirásek M; Celakovský P; Vosmiková H; Ryska A
Pathol Res Pract; 2008; 204(8):545-52. PubMed ID: 18440161
[TBL] [Abstract][Full Text] [Related]
30. Metastatic HPV-related cervical adenocarcinomas presenting with thromboembolic events (Trousseau Syndrome): clinicopathologic characteristics of 2 cases.
Veras E; Srodon M; Neijstrom ES; Ronnett BM
Int J Gynecol Pathol; 2009 Mar; 28(2):134-9. PubMed ID: 19188822
[TBL] [Abstract][Full Text] [Related]
31. Bowen's disease on the sole: p16INK4a overexpression associated with human papillomavirus type 16.
Murao K; Kubo Y; Takiwaki H; Arase S; Matsumoto K
Br J Dermatol; 2005 Jan; 152(1):170-3. PubMed ID: 15656821
[TBL] [Abstract][Full Text] [Related]
32. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
[TBL] [Abstract][Full Text] [Related]
33. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
Khouja MH; Baekelandt M; Nesland JM; Holm R
Int J Gynecol Pathol; 2007 Oct; 26(4):418-25. PubMed ID: 17885492
[TBL] [Abstract][Full Text] [Related]
34. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical expression of p16INK4a and HPV L1 capsid proteins as predictive markers of the cervical lesions progression risk.
Ungureanu C; Socolov D; Anton G; Mihailovici MS; Teleman S
Rom J Morphol Embryol; 2010; 51(3):497-503. PubMed ID: 20809026
[TBL] [Abstract][Full Text] [Related]
36. Traditional and new molecular methods for early detection of cervical cancer.
Dallenbach-Hellweg G; Trunk MJ; von Knebel Doeberitz M
Arkh Patol; 2004; 66(5):35-9. PubMed ID: 15575385
[TBL] [Abstract][Full Text] [Related]
37. [Expression of p16INK4a in various cancer cells].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Frank GA; Golovina DA; Spitkovskiĭ DD
Arkh Patol; 2004; 66(5):3-5. PubMed ID: 15575375
[TBL] [Abstract][Full Text] [Related]
38. P16(INK4a) overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas.
Giordano G; Azzoni C; D'Adda T; Merisio C
Pathol Res Pract; 2007; 203(7):533-8. PubMed ID: 17498885
[TBL] [Abstract][Full Text] [Related]
39. p16INK4a and laminin-5gamma2 chain expression during the progression of cervical neoplasia.
Wang JL; Andersson S; Li X; Hellström AC; Auer G; Angström T; Lindström MS; Wallin KL
Acta Oncol; 2006; 45(6):676-84. PubMed ID: 16938810
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.
Dabić MM; Nola M; Tomicić I; Dotlić S; Petrovecki M; Jukić S
Acta Obstet Gynecol Scand; 2008; 87(3):366-72. PubMed ID: 18307079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
